Legal Representation
Attorney
Robert L. Powley
USPTO Deadlines
Next Deadline
895 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-01-11)
Due Date
January 11, 2028
Grace Period Ends
July 11, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 10, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Jul 18, 2022 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Jun 23, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Jun 22, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Apr 11, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jan 11, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 19, 2021 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Dec 1, 2021 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Dec 1, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Nov 4, 2021 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Oct 26, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 26, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 6, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 6, 2021 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Oct 6, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Sep 19, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 9, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 8, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 8, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 23, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Mar 12, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 12, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 12, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 11, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 10, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 10, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 3, 2020 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Sep 12, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Sep 12, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Aug 15, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Aug 14, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 13, 2020 | RFWR | P | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | Loading... |
| Jun 30, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jun 28, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jun 27, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 26, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 26, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 25, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Medicinal and pharmaceutical preparations and substances for the treatment of degenerative and neurological diseases; medicinal and pharmaceutical preparations and substances for the treatment of central nervous system disorders and for use in treatment of disorders of the endocrine, cardiovascular, renal, skeletal, immune and metabolic systems
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical evaluation of degenerative and neurological diseases, central nervous system disorders, and disorders of the endocrine, cardiovascular, renal, skeletal, immune and metabolic systems; medical diagnosis of degenerative and neurological diseases, central nervous system disorders, and disorders of the endocrine, cardiovascular, renal, skeletal, immune and metabolic systems; medical services for the treatment of degenerative and neurological diseases, central nervous system disorders, and disorders of the endocrine, cardiovascular, renal, skeletal, immune and metabolic systems and physical rehabilitation; provision of medical information; providing information relating to diagnostic, phophylactic and therapeutic properties of pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the stylized wording "LUPIN" above the stylized wording "NEUROSCIENCES". To the left of the wording is a thin vertical line. To the left of the line is the design of a partial silhouette of the side of a face. To the left side of the face is a six-petal flower on the top left.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"NEUROSCIENCES"